Increased lipids in non-lipogenic tissues are indicators of the severity of type 2 diabetes in mice

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 76, Issue 1, 2007, Pages 9-18

  Campbell Tofte, Joan ^a   Hansen, Harald S ^a   Mu, Huiling ^b   Mølgaard, Per ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; FAT; LINOLEIC ACID; LINOLENIC ACID; LIPID; MONOUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EYE; LEAN BODY WEIGHT; LIPID STORAGE; LIVER; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TISSUE LEVEL;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; EYE; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; MALE; MICE; MICE, OBESE; MUSCLE, SKELETAL; PANCREAS; PHOSPHOLIPIDS; STEAROYL-COA DESATURASE; TRIGLYCERIDES;

EID: 33845931323     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.09.002     Document Type: Article

References (35)

1. Vessby B. Dietary fat and insulin action in human. Br. J. Nutr. 83 Suppl. 1 (2000) S91-S96
2. Clore J.N., Harris P.A., Li J., Azzam A., Gill R., Zuelzer W., Rizzo W.B., and Blackard W.G. Changes in phosphatidylcholine fatty acid composition are associated with altered skeletal muscle insulin responsiveness in normal man. Metab.: Clin. Exp. 49 (2000) 2332-2338
3. Lan H., Rabaglia M.E., Stoehr J.P., Nadler S.T., Schueler K.L., Zou F., Yandell B.S., and Attie A.D. Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility. Diabetes 52 (2003) 688-700
4. Shimomura I., Bashmakov Y., and Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of obesity and diabetes mellitus. J. Biol. Chem. 274 (1999) 30028-30032
5. Campbell J.I.A., Mortensen A., and Mølgaard P. Tissue lipid-lowering effect of a traditional Nigerian anti-diabetic infusion of Rauwolfia vomitoria foliage & Citrus aurantium fruit. J. Ethnopharmacol. 104 (2006) 379-386
6. Coleman D.L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14 (1978) 141-148
7. Lord J.M., and Atkins T.W. Effect of age on hepatocyte and soleus muscle insulin receptor binding in lean and genetically obese diabetic (ob/ob) mice. Diabetes Res. 2 (1985) 259-265
8. Leiter E.H., Prochazka M., and Shultz L.D. Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice. J. Immunol. 138 (1987) 3224-3229
9. Bray G.A., and York D.A. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol. Rev. 59 (1979) 719-809
10. Giacomelli F., and Wiener J. Primary myocardial disease in the diabetic mouse. An ultra-structural study,. Lab. Invest. 40 (1979) 460-473
11. Davis R.C., Schadt E.E., Cervino A.C.L., Peterfy M., and Lusis A.J. Ultrafine mapping of SNPs from mouse strains C57BL/6J, DBA/2J, and C57BLKS/J for loci contributing to diabetes and atherosclerosis susceptibility. Diabetes 54 (2005) 1191-1199
12. Schiekofer S., Galasso G., Sato K., Kraus B.J., and Walsh K. Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1603-1609
13. Bagi Z., Erdei N., Toth A., Li W., Hintze T.H., Koller A., and Kaley G. Type 2 diabetic mice have increased arteriolar tone and blood pressure. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1610-1616
14. Mu H., and Høy C.-E. Distribution of medium chain fatty acids in different lipid classes after administration of specific structured triacylglycerols in rats. Lipids 37 (2002) 329-331
15. Thorling E.B., and Hansen H.S. Age-related changes in the percentages of oleate in adipose tissue of male and female Fischer rats. Biochim. Biophys. Acta 1258 (1995) 195-198
16. Mutch D.M., Grigorov M., Berger A., Fay L.B., Roberts M.A., Watkins S.M., Williamson G., and German J.B. An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet. FASEB J. 18 (2005) 599-601
17. Risérus U., Tan G.D., Fielding B.A., Neville M.J., Currie J., Savage D.B., Chatterjee V.K., Frayn K.N., O'Rahilly S., and Karpe F. Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferators-activated receptor-gamma. Diabetes 54 (2005) 1379-1384
18. Lin X., Yue P., Chen Z., and Schonfeld G. Hepatic triglyceride contents are genetically determined in mice: results of a survey. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005) G1179-G1189
19. Park I.H., and Chen J. Mammalian target of rapamycin (mTOR) signalling is required for late-stage fusion process during skeletal myotube maturation. J. Biol. Chem. 280 (2005) 32009-32017
20. Miyazaki M., Gomez F.E., and Ntambi J.M. Lack of stearoyl-CoA desaturase-1 function induces a palmitoyl-CoA Δ6 desaturase and represses the stearoyl-CoA desaturase-3 gene in the preputial glands of the mouse. J. Lipid Res. 43 (2002) 2146-2154
21. Miyazaki M., Jacobson M.J., Man W.C., Cohen P., Asilmaz E., Friedman J.M., and Ntambi J.M. Identification and characterisation of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors. J. Biol. Chem. 278 (2003) 33904-33911
22. Cohen P., Miyazaki M., Socci N.D., Hagge-Greenberg A., Liedtke W., Soukas A.A., Sharma R., Hudgins L.C., Ntambi J.M., and Friedman J.M. Role for stearoyl-CoA desaturase-1 in leptin-medicated weight loss. Science 297 (2002) 240-243
23. Ntambi J.M., Miyazaki M., Stoehr J.P., Lan H., Kendziorski C.M., Yandell B.S., Song Y., Cohen P., Friedman J.M., and Attie A.D. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. USA 99 (2002) 11482-11486
24. Rahman S.M., Dobrzyn A., Dobrzyn P., Lee S.H., Miyazaki M., and Ntambi J.M. Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc. Natl. Acad. Sci. USA 100 (2003) 11110-11115
25. Nadler S.T., and Attie A.D. Please pass the chips: genomic insights into obesity and diabetes. J. Nutr. 131 (2001) 2078-2081
26. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
27. Lombardo Y.B., and Chicco A.G. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J. Nutr. Biochem. 17 (2006) 1-13
28. In: Brenner R.R. (Ed). Editorials. Prostaglandins Leukot Essent Fatty Acids 68 (2003) 151-162
29. Mercuri O., Peluffo R.O., and Brenner R.R. Effect of insulin on the oxidative desaturation of gamma-linolenic, oleic and palmitic acids. Lipids 2 (1967) 284-285
30. Suresh T., and Das U.N. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of omega-3 fatty acids. Nutrition 19 (2003) 213-228
31. Shureiqi I., Jiang W., Zuo X., Wu Y., Stimmel J.B., Leesnitzer L.M., Morris J.S., Fan H.-Z., Fischer S.M., and Lippman S.M. The 15-lipoxygenase-1 product 13-S- hydroxyoctadecadienoic acid down regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 9968-9973
32. Nixon J.B., Kim K.S., Lamb P.W., Bottone F.G., and Eling T.E. 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004) 7-15
33. db/db mice with type 2 diabetes. Diabetes 54 (2005) 2328-2335
34. Garris D.R. Diabetes (db/db) mutation-induced endometrial epithelial lipoapoptosis: Ultrastructural and cytochemical analysis of reproductive tract atrophy. Reprod. Biol. Endocrinol. 3 1 (2005) 15
35. Garris D.R. Cytochemical analysis of pancreatic islet lipoaptosis: hyperlipidemia-induced cytoinvolution following expression of the diabetes (db/db) mutation. Pathobiol. 72 (2005) 124-132